An "interval cancer" is a patient's worst nightmare: a tumor discovered between two routine screenings.
A woman leaves her mammogram with a clean bill of health, but months later feels a lump, returns for an emergency appointment, and learns the diagnosis.
These missed cancers are notoriously aggressive and fast-growing.
To fight this, the Swedish MASAI (Mammography Screening with Artificial Intelligence) study tested whether AI could help doctors spot these hidden threats before patients find them themselves.

Study methodology
This landmark trial evaluated nearly 106,000 women aged 40 to 80. Participants were split into two groups: one followed the traditional European standard of independent double-reading by two human radiologists, while the other used an AI-supported workflow where a single radiologist was assisted by an AI system flagging suspicious areas on the scans.

Interval cancer rates
The integration of AI successfully led to 11 fewer interval cancers over two years a 12% drop compared to the purely human approach. By acting as an ultra-precise digital highlighter, the AI allowed doctors to catch these elusive, fast-growing tumors during the routine check-up rather than leaving them to progress undetected.

Sensitivity and Workload Optimization
AI boosted screening sensitivity to 80.5% (up from 73.8% in the control group) without increasing false positives. Crucially, because the AI allowed a single radiologist to do the work of two safely, it slashed the medical workload by 44%, offering a concrete solution to the global shortage of healthcare staff.

The final take : the 9% sensitivity shift confirms AI triage is strategic for paving the way toward augmented radiology
The data confirms a decisive pivot toward clinical collaboration: the AI acts as a digital safety net by processing mammograms as massive data matrices.
Trained on thousands of complex medical images, the algorithms compute millions of parameters in seconds to flag subtle anomalies and noise patterns invisible to the naked eye.
By instantly highlighting these hidden, early-stage risks on the screen, the technology enhances human perception. The radiologist retains full final authority, but his practice is now augmented to prevent aggressive interval cancers before they progress.

 Read the Euronews article and the full study